Related Experiment Videos
[Kawasaki syndrome]
A Bourrillon1, E Seban, C Vitoux-Brot
1Service du Pr Bourrillon, Hôpital Robert Debré, Paris.
Insights
Kawasaki disease is an immune vasculitis, often with subtle symptoms, leading to potential heart issues. Early treatment with gammaglobulins and aspirin effectively prevents coronary artery aneurysms.
Area of Science:
- Pediatric Rheumatology
- Infectious Immunology
Context:
- Kawasaki disease is characterized by immune-mediated vasculitis, likely triggered by an infection.
- Atypical or oligosymptomatic presentations are common, potentially delaying diagnosis and impacting cardiovascular outcomes.
- Coronary artery lesions are a significant concern, well-documented through echocardiographic studies.
Purpose:
- To review current understanding of Kawasaki disease etiology and presentation.
- To highlight the diagnostic challenges posed by atypical forms.
- To summarize effective therapeutic strategies for preventing cardiac sequelae.
Summary:
- Kawasaki disease is increasingly viewed as a hyperimmune vasculitis of probable infectious origin.
- The disease frequently presents with subtle or atypical symptoms, complicating recognition and management.
- Echocardiography has clarified the spectrum of cardiac lesions, particularly coronary artery aneurysms.
- Intravenous gammaglobulins and acetylsalicylic acid are proven effective in preventing coronary aneurysm formation.
Impact:
- Advances in understanding and treatment necessitate a re-evaluation of diagnostic and prognostic criteria for Kawasaki disease.
- Current findings pave the way for further research into disease mechanisms and therapeutic targets.
- Improved diagnostic and therapeutic approaches can enhance cardiovascular outcomes in affected children.
Abstract:
Recent studies support the hypothesis that Kawasaki disease is due to a hyperimmune vasculitis, probably of infectious origin. In addition, current data highlight the frequency of atypical (oligosymptomatic) aspects of the disease which may not be recognized, thereby worsening its cardiovascular prognosis. The types of cardiac lesions encountered, notably those of the coronary arteries, have now been well established by sequential echocardiographic studies. Several therapeutic trials have confirmed the effectiveness of gammaglobulins (400 mg/kg.day) and acetylsalicylic acid in preventing the formation of coronary aneurysms. These recent advances in the understanding and treatment of Kawasaki disease may lead to a reappraisal of its diagnostic and prognostic criteria and open the way to multiple lines of research.